Hepatocyte growth factor activator (HGFA) is a
serine protease and a potent activator of prohepatocyte
growth factor/
scatter factor (
pro-HGF/SF), a multifunctional
growth factor that is critically involved in tissue morphogenesis, regeneration, and
tumor progression. HGFA circulates as a
zymogen (pro-HGFA) and is activated in response to tissue injury. Although
thrombin is considered to be an activator of pro-HGFA, alternative pro-HGFA activation pathways in tumor microenvironments remain to be identified. In this study, we examined the effects of
kallikrein 1-related
peptidases (KLKs), a family of extracellular
serine proteases, on the activation of pro-HGFA. Among the KLKs examined (KLK2, KLK3, KLK4 and KLK5), we identified KLK4 and KLK5 as novel activators of pro-HGFA. Using N-terminal sequencing, the cleavage site was identified as the normal processing site, Arg407-Ile408. The activation of pro-HGFA by KLK5 required a negatively charged substance such as
dextran sulfate, whereas KLK4 could process pro-HGFA without
dextran sulfate. KLK5 showed more efficient pro-HGFA processing than KLK4, and was expressed in 50% (13/25) of the tumor cell lines examined. HGFA processed by these KLKs efficiently activated
pro-HGF/SF, and led to cellular scattering and invasion in vitro. The activities of both KLK4 and KLK5 were strongly inhibited by HGFA inhibitor type 1, an integral membrane Kunitz-type
serine protease inhibitor that inhibits HGFA and other
pro-HGF/SF-activating
proteases. These data suggest that KLK4 and KLK5 mediate HGFA-induced activation of
pro-HGF/SF within
tumor tissue, which may thereafter trigger a series of events leading to
tumor progression via the MET receptor.